"Placebos" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol.
| Descriptor ID |
D010919
|
| MeSH Number(s) |
D26.660 E02.785
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Placebos".
Below are MeSH descriptors whose meaning is more specific than "Placebos".
This graph shows the total number of publications written about "Placebos" by people in this website by year, and whether "Placebos" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 2 | 1 | 3 |
| 2004 | 1 | 1 | 2 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 4 | 4 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 2 | 2 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 2 | 42 | 44 |
| 2018 | 3 | 34 | 37 |
| 2019 | 0 | 17 | 17 |
| 2020 | 1 | 8 | 9 |
| 2021 | 3 | 12 | 15 |
To return to the timeline, click here.
Below are the most recent publications written about "Placebos" by people in Profiles.
-
Safety and immunogenicity of a recombinant interferon-armed RBD dimer vaccine (V-01) for COVID-19 in healthy adults: a randomized, double-blind, placebo-controlled, Phase I trial. Emerg Microbes Infect. 2021 Dec; 10(1):1589-1597.
-
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial. Nat Med. 2021 10; 27(10):1752-1760.
-
Restrictions on the use of placebo in new COVID-19 vaccine trials. Eur J Clin Pharmacol. 2022 Jan; 78(1):147-148.
-
Hydroxychloroquine plus azithromycin early treatment of mild COVID-19 in an outpatient setting: a randomized, double-blinded, placebo-controlled clinical trial evaluating viral clearance. Int J Antimicrob Agents. 2021 Nov; 58(5):106428.
-
Current COVID-19 vaccine trials in high-income countries: are placebo-controlled trials ethical? Clin Microbiol Infect. 2021 11; 27(11):1565-1567.
-
Ivermectin for preventing and treating COVID-19. Cochrane Database Syst Rev. 2021 07 28; 7:CD015017.
-
Placebo-controlled trials with COVID-19 vaccines: participants first. J Clin Epidemiol. 2021 10; 138:211-212.
-
Understanding and predicting COVID-19 clinical trial completion vs. cessation. PLoS One. 2021; 16(7):e0253789.
-
Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial. BMC Infect Dis. 2021 Jul 02; 21(1):635.
-
Audio Interview: Another New Covid-19 Vaccine. N Engl J Med. 2021 07 01; 385(1):e13.